Azitra (AZTR) Change in Cash (2022 - 2026)
Azitra (AZTR) posted Change in Cash of $8.0 million for Q1 2026, up 1098.27% on a QoQ basis from $666205.0 in Q4 2025, and up 692.2% year-over-year from $1.0 million in Q1 2025.
Azitra (AZTR) Change in Cash (2022 - 2026) Analysis & Trends
Azitra's Change in Cash history runs 5 years deep, the most recent figure standing at $8.0 million for Q1 2026.
- Quarterly Change in Cash rose 692.2% year-over-year to $8.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.8 million (up 3229.71% YoY) and the FY2025 annual result came in at -$2.5 million, down 190.14% from the prior year.
- Change in Cash was $8.0 million for Q1 2026 at Azitra, up from $666205.0 in the prior quarter.
- Across five years, Change in Cash topped out at $8.0 million in Q1 2026 and bottomed at -$2.7 million in Q4 2024.
- A 5-year average of $419977.9 and a median of -$1.3 million in 2025 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2025 — Change in Cash tumbled 211.85% — and 2026, when it soared 692.2%.
- Azitra's Change in Cash stood at -$2.4 million in 2022, then retreated by 6.49% to -$2.6 million in 2023, then declined by 3.88% to -$2.7 million in 2024, then surged by 124.62% to $666205.0 in 2025, then soared by 1098.27% to $8.0 million in 2026.
- Business Quant data shows AZTR's Change in Cash at $8.0 million in Q1 2026, $666205.0 in Q4 2025, and $356148.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,792.52 Bn | 1,792.46 Bn | - | - |
| 2 | Akari Therapeutics | 999.95 Bn | 999.95 Bn | - | -2.44 Mn |
| 3 | BeOne Medicines | 475.97 Bn | 471.17 Bn | 1.35 Bn | 243.78 Mn |
| 4 | Vertex Pharmaceuticals | 124.91 Bn | 117.66 Bn | 2.59 Bn | 417.10 Mn |
| 5 | Regeneron Pharmaceuticals | 72.31 Bn | 63.56 Bn | 3.31 Bn | -153.10 Mn |
| 6 | Belite Bio | 62.01 Bn | 62.01 Bn | - | - |
| 7 | Argenx Se | 54.23 Bn | 49.04 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.31 Bn | 35.30 Bn | 959.66 Mn | 53.61 Mn |
| 9 | Revolution Medicines | 36.16 Bn | 36.16 Bn | - | 57.19 Mn |
| 10 | Azitra | 2.05 Mn | 2.05 Mn | - | 7.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.98 Mn |
| Dec 31, 2025 | 666,205.00 |
| Sep 30, 2025 | 356,148.00 |
| Jun 30, 2025 | -2.16 Mn |
| Mar 31, 2025 | -1.35 Mn |
| Dec 31, 2024 | -2.71 Mn |
| Sep 30, 2024 | 6.46 Mn |
| Jun 30, 2024 | -2.20 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | -2.60 Mn |
| Sep 30, 2023 | -1.89 Mn |
| Jun 30, 2023 | 4.46 Mn |
| Mar 31, 2023 | -1.66 Mn |
| Dec 31, 2022 | -2.45 Mn |
| Sep 30, 2022 | 2.19 Mn |